Redhawk Wealth Advisors Inc. Purchases New Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Redhawk Wealth Advisors Inc. purchased a new position in UnitedHealth Group Incorporated (NYSE:UNH) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,072 shares of the healthcare conglomerate’s stock, valued at approximately $546,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Delos Wealth Advisors LLC grew its position in shares of UnitedHealth Group by 757.1% during the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after buying an additional 53 shares in the last quarter. True Wealth Design LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter valued at about $31,000. Bbjs Financial Advisors LLC purchased a new position in UnitedHealth Group during the second quarter valued at approximately $31,000. Red Tortoise LLC increased its holdings in shares of UnitedHealth Group by 45.1% in the 1st quarter. Red Tortoise LLC now owns 74 shares of the healthcare conglomerate’s stock valued at $36,000 after acquiring an additional 23 shares during the period. Finally, Ruedi Wealth Management Inc. boosted its position in UnitedHealth Group by 58.3% during the first quarter. Ruedi Wealth Management Inc. now owns 76 shares of the healthcare conglomerate’s stock valued at $38,000 after purchasing an additional 28 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 0.0 %

Shares of UNH traded down $0.06 during mid-day trading on Thursday, reaching $579.61. The stock had a trading volume of 2,738,085 shares, compared to its average volume of 4,237,663. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.85. The firm has a market cap of $533.46 billion, a price-to-earnings ratio of 35.38, a P/E/G ratio of 1.56 and a beta of 0.59. The business’s fifty day moving average is $526.09 and its 200 day moving average is $506.41. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $591.54.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, beating analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The firm had revenue of $98.86 billion for the quarter, compared to analysts’ expectations of $98.73 billion. During the same period in the prior year, the firm posted $6.14 earnings per share. The firm’s quarterly revenue was up 6.4% on a year-over-year basis. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.45%. The ex-dividend date is Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is 51.34%.

Insider Buying and Selling at UnitedHealth Group

In related news, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at $16,812,029.88. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The disclosure for this sale can be found here. 0.33% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on UNH. Baird R W raised shares of UnitedHealth Group to a “strong-buy” rating in a research report on Thursday, May 30th. Jefferies Financial Group raised UnitedHealth Group from a “hold” rating to a “buy” rating and upped their target price for the company from $481.00 to $647.00 in a research report on Wednesday, July 17th. Piper Sandler raised their price target on shares of UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a report on Wednesday, April 17th. UBS Group upped their target price on UnitedHealth Group from $640.00 to $680.00 and gave the company a “buy” rating in a research report on Thursday, July 18th. Finally, HSBC boosted their price target on UnitedHealth Group from $580.00 to $610.00 in a research note on Thursday, July 18th. One research analyst has rated the stock with a hold rating, nineteen have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Buy” and a consensus target price of $614.17.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.